Elicio Therapeutics (ELTX) Earnings Date & Reports

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ELTX is expected to report earnings to -64 cents per share on August 07

Elicio Therapeutics ELTX Stock Earnings Reports

Q2'26

Est.

$-0.65

Q1'26

Missed

by $0.04

Q4'25

Beat

by $0.19

Q3'25

Beat

by $0.08

Q2'25

Beat

by $0.01

The last earnings report on May 11 showed earnings per share of -64 cents, missing the estimate of -61 cents. With 127.12K shares outstanding, the current market capitalization sits at 271.02M.

View a ticker or compare two or three

Compare

ELTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ELTX